Emerging from the UK, retatrutide, a innovative molecule, is sparking considerable interest within the scientific community regarding its ability for body management . This dual GIP and GLP-1 receptor agonist appears to deliver a considerable advantage over established therapies, showing promising results in early clinical studies . Researchers bel